Vijay K. Patel and Harish Rajak* Pages 931 - 939 ( 9 )
A series of novel N-substituted-2-amino-3,4,5-trimethoxybenzoylindoles was synthesized and assessed against human cancer cell lines of breast (MCF-7) and colon (HT-29). The two derivatives 7a and 11a, in which the hydrogen atom at position 1 was substituted by a methyl and a benzoyl group respectively, showed significant cytotoxic activity GI50 against MCF-7 (0.045 µM), HT-29 (4.25 µM) and MCF-7 (0.035 µM) HT-29 (0.856 µM). Molecular docking studies indicated that compounds 7a and 11a possess hydrogen bond interaction between SH group of Cys 241 of receptor molecule and para position of trimethoxyphenyl group of benzoyl moiety, while compound 11a has an extra hydrogen bond interaction between Ser 178 of receptor molecule and keto group of benzoyl moiety. The compound 11a showed high solvent-exposed penalty due to the presence of phenyl ring of benzoyl molecule, thus compound 11a showed low Gscore and lesser potent as compared to 7a.
Anticancer, combretastatin A-4, docking, N-substituted-2-amino-3, 4, 5-trimethoxybenzoylindole, synthesis, MCF-7.
Medicinal Chemistry Research Laboratory, SLT Institute of Pharmaceutical Sciences, Guru Ghasidas University, Bilaspur- 495 009, (C.G.), Medicinal Chemistry Research Laboratory, SLT Institute of Pharmaceutical Sciences, Guru Ghasidas University, Bilaspur- 495 009, (C.G.)